Call 408.493.1800 | Fax 408.493.1801 | Toll Free 800.891.9699 (US Only) | Email: [email protected]

BCL2 Protein, Human Recombinant

Human Recombinant protein
Catalog #: P1627
SKU-Size Size Price Qty
P1627-20 20 μg
$225.00
P1627-50 50 μg
$325.00
More Sizes Get Quote

Product Details

Alternate Name BCL2 apoptosis regulator; PPP1R50; B - cell CLL/lymphoma 2; Protein phosphatase 1; Regulatory subunit 50; BCL - XL
Gene Symbol 231632
Gene ID 596
Accession # NP_000624.2, P10415
Source E.coli
Appearance Liquid
Molecular Weight 25 kDa
Purity by SDS-PAGE ≥ 95%
Amino Acid Sequence The target protein is expressed with sequence (Ala2-Asp211) of human BCL2.
Handling Centrifuge the vial prior to opening.
Storage Conditions -20ºC
Shipping Conditions Gel Pack
USAGE For Research Use Only! Not For Use in Humans.

Details

BCL-2 was the first anti-death gene discovered with far reaching implications in tumor biology. It regulates cell death by either inhibiting (anti-apoptotic) or inducing (pro-apoptotic) apoptosis. The BCL-2 protein is the founding member of the BCL-2 family of apoptosis regulators and was the first apoptosis modulator to be associated with cancer. It suppresses apoptosis in a variety of cell systems including factor-dependent lymphohematopoietic and neural cells. BCL-2 regulates cell death by controlling the mitochondrial membrane permeability.


Why buy BioVision Products?
Innovation
Affordability
Global Presence
Technical Support
BioVision aims to provide our customers innovative tools for accelerating drug discovery and biological research. BioVision offers >8,000 products including the most comprehensive array of assay kits for key targets in Metabolic pathways.
BioVision is committed to providing the highest quality products at a competitive price.
We have a broad network of global distributors who are ready to address your research needs and ensure fast delivery.
Our highly trained Technical Support team provides comprehensive product support and is dedicated to resolving your issues quickly and efficiently.